Skip to search.
 FTSE 100 Down 0.86%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
396.61 Down 15.98(3.87%) 5 Feb 21:00
|After Hours: : 397.66 Up 1.05 (0.26%) 6 Feb 00:57
Prev Close:412.59
Open:416.10
Bid:390.00 x 100
Ask:412.20 x 200
1y Target Est:594.30
Beta:1.80611
Next Earnings Date: 9-Feb-16REGN Earnings announcement
Day's Range:393.07 - 420.53
52wk Range:392.35 - 605.93
Volume:1,432,659
Avg Vol (3m):809,280
Market Cap:42.06b
P/E (ttm):78.33
EPS (ttm):5.06
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 3.87%42.06b
AMGNDown 3.25%109.36b

Key Statistics

Forward P/E (1 yr):28.29
P/S (ttm):11.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :12.53
Quarterly EPS Est (Dec-15) :3.31
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):1.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback